GeneCapture, Inc., Alabama, United States
Keywords: Rapid, Diagnostic, Portable, Infection, MolecularGeneCapture is developing a novel platform to enable point-of-care infection diagnosis for the warfighter and public health applications. Scientists at GeneCapture have validated the rapid ID of pathogens from clinical samples and are now maturing the technology for testing. The poster proposed will update the Science & Technology visitors with the current outcomes and an overview of the platform technology which involves targeting the pathogenic RNA from human or animal samples. The technique is very novel in that no modification or amplification of the sample is required, thus minimizing many of the cost and logistics concerns for on-site testing. GeneCapture is performing on an STTR Phase II contract with Defense Threat Reduction Agency (Quad Chart attached) and was recently selected as a US ARMY protégé in the Mentor Protégé program. Status updates on both will be provided. PACOM has unique infectious threats to the warfighter and we believe your conference visitors will be interested in the results we will present.